Atlas Trials

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Clinical trial NCT06051786 · COMPLETED

Trial details

NCT number
NCT06051786
Sponsor
Synmosa Biopharma Corp.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Allergic Rhinitis
Start date
2020-08-20
Primary completion
2021-07-20
Enrollment
136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.